Thromboxane A2 and airway responsiveness to acetylcholine aerosol in the conscious primate.
Letts
G L
GL
Department of Pharmacology, Merck Frosst Canada Inc., Pointe Claire-Dorval, Québec.
McFarlane
C S
CS
D000109:Acetylcholine / Q000633:toxicity*; D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects; D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000139:chemically induced* / Q000188:drug therapy; D003243:Consciousness; D007211:Indoles / Q000627:therapeutic use; D008170:Lung Compliance / Q000187:drug effects; D011450:Prostaglandin Endoperoxides, Synthetic / Q000633:toxicity; D012453:Saimiri; D013928:Thromboxane A2 / Q000037:antagonists & inhibitors / Q000502:physiology*
D000336:Aerosols; D001713:Biphenyl Compounds; D007211:Indoles; D011450:Prostaglandin Endoperoxides, Synthetic; C052517:L 655240; C028429:U 44069; D013928:Thromboxane A2; C046926:AH 23848; D000109:Acetylcholine